impassion130 and impassion131: the difference a taxane makes? | leisha emens
Published 3 years ago • 684 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
2:51
impassion130: design and preliminary efficacy
-
0:59
impassion130 data demonstrate clinical benefit for immunotherapy in metastatic tnbc
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
6:33
case 3: results of the impassion130 trial in metastatic breast cancer
-
3:50
breast cancer at esmo 2020: impassion131, solar-1, pallas and more
-
2:19
elizabeth mittendorf, md, phd, on the implications of the impassion-130 and impassion-131 trials
-
4:15
impassion130: atezolizumab (atezo) nab-paclitaxel (nab-p) vs placebo nab-p in treatment-naiv...
-
28:27
dr. jayendran dharmaratnam: rawatan imunoterapi | dingar cakap doktor
-
22:26
triple-negative breast cancer: what's new in treatment and research at mbc patient forum 2019
-
9:59
impower130 trial of carbo/nab-pac /- atezo: does this positive trial change management? (bmic-071)
-
4:11
immunotherapy for tnbc: impassion130 & keynote-355
-
4:27
the impassion130 study in metastatic tnbc
-
7:36
esmo 2020 expert video report on atezolizumab in upfront treatment of tnbc
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial
-
6:56
impassion130 trial data on pd-l1 tumors in tnbc
-
6:54
impassion130 trial data on pd-l1 tumors in tnbc
-
2:30
impassion130: immunotherapy for tnbc
-
2:33
applying impassion130 data to tnbc management
-
4:47
tnbc: updated efficacy results from impassion130
-
1:16
the impassion130 trial in metastatic triple-negative breast cancer
-
1:00
impassion130: implications